@Article{Zeng2023,
journal="Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii",
issn="1642-395X",
volume="40",
number="6",
year="2023",
title="Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials",
author="Zeng, Linxi
and Feng, Sen
and Yao, Lulu
and Wang, Bin
and Zhang, Guoqiang",
pages="734--740",
doi="10.5114/ada.2023.133959",
url="http://dx.doi.org/10.5114/ada.2023.133959"
}